Press Releases

Company News
View Summary Jul 23, 2015
NeoGenomics Reports 18% Revenue Growth and Strong Gains in Adjusted EBITDA
PDF 33.6 KB Add to Briefcase
View Summary Jul 22, 2015
NeoGenomics Expands Multimodality Cancer Profile Testing
PDF 172.6 KB Add to Briefcase
View Summary Jul 20, 2015
NeoGenomics Launches Germline Cancer Predisposition Testing
PDF 172.2 KB Add to Briefcase
View Summary Jun 30, 2015
NeoGenomics Schedules its Q2 2015 Earnings Release for July 23, 2015
PDF 127.6 KB Add to Briefcase
View Summary Jun 17, 2015
NeoGenomics Announces New Directors
PDF 13.8 KB Add to Briefcase
  Jun 16, 2015
NeoGenomics Set to Join Russell 3000 Index
PDF 162.2 KB Add to Briefcase
View Summary Jun 11, 2015
NeoGenomics Launches Twelve NeoLAB™ "Liquid Biopsy" Tests for Hematologic Diseases
PDF 183.3 KB Add to Briefcase
View Summary Apr 28, 2015
NeoGenomics Reports 27% Revenue Growth Driven by Strong Volume Gains and PathLogic Acquisition
PDF 260.6 KB Add to Briefcase
  Apr 23, 2015
NeoGenomics Announces Promotions
PDF 206.1 KB Add to Briefcase
View Summary Apr 16, 2015
NeoGenomics Schedules its Q1 2015 Earnings Release for April 28, 2015
PDF 13.9 KB Add to Briefcase
View Summary Feb 24, 2015
NeoGenomics Reports Record Revenue of $25.0 Million, Adjusted EBITDA of $2.8 MM and Net Income of $0.02 per Share for the Fourth Quarter 2014
PDF 115.1 KB Add to Briefcase
View Summary Feb 23, 2015
NeoGenomics to Host Fourth Quarter and Fiscal Year 2014 Earnings Conference Call and Webcast Live on Tuesday, February 24, 2015
PDF 12.1 KB Add to Briefcase
View Summary Feb 4, 2015
NeoGenomics Schedules its Q4 2014 and Full Year 2014 Earnings Release for February 24, 2015
PDF 31.0 KB Add to Briefcase
  Jan 22, 2015
NeoGenomics Raises Revenue Guidance to $25 Million and EPS Guidance to $0.01 - $0.02 per share for Quarter 4, 2014
PDF 84.3 KB Add to Briefcase
View Summary Dec 16, 2014
NeoGenomics, the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and the Northwestern Medicine Developmental Therapeutics Institute Launch Collaborative Translational Research Program
PDF 52.3 KB Add to Briefcase
View Summary Oct 30, 2014
NeoGenomics Reports 38% increase in Revenue to a Record $23.2 Million and Adjusted EBITDA of $2.6 Million for the Third Quarter of 2014
PDF 115.3 KB Add to Briefcase
View Summary Oct 29, 2014
NeoGenomics to Host Third Quarter 2014 Earnings Conference Call and Webcast Live on Thursday, October 30, 2014
PDF 12.4 KB Add to Briefcase
View Summary Oct 23, 2014
NeoGenomics is First to Offer Molecular Testing for Resistance to Bruton Tyrosin Kinase Inhibitors for Chronic Lymphocytic Leukemia
PDF 15.0 KB Add to Briefcase
View Summary Oct 16, 2014
NeoGenomics Launches 315 Gene Next Generation Sequencing Test for Solid Tumor Discovery Profiling
PDF 55.7 KB Add to Briefcase
View Summary Sep 29, 2014
NeoGenomics Appoints Robert J. Shovlin as Chief Operating Officer
PDF 11.9 KB Add to Briefcase
Showing 1-20 of 79 Page: 1 2 3 4  Next 20
Add to Briefcase = add release to Briefcase